City Research Online

Color Vision in Blue Cone Monochromacy: Outcome Measures for a Clinical Trial

Mascio, A. A., Roman, A. J., Cideciyan, A. V. , Sheplock, R., Wu, V., Garafalo, A. V., Sumaroka, A., Pirkle, S., Kohl, S., Wissinger, B., Jacobson, S.G. & Barbur, J. L. ORCID: 0000-0002-2187-5004 (2023). Color Vision in Blue Cone Monochromacy: Outcome Measures for a Clinical Trial. Translational Vision Science & Technology, 12(1), article number 25. doi: 10.1167/tvst.12.1.25

Abstract

PURPOSE: Blue cone monochromacy (BCM) is an X-linked retinopathy due to mutations in the OPN1LW/OPN1MW gene cluster. Symptoms include reduced visual acuity and disturbed color vision. We studied BCM color vision to determine outcome measures for future clinical trials.

METHODS: Patients with BCM and normal-vision participants were examined with Farnsworth-Munsell (FM) arrangement tests and the Color Assessment and Diagnosis (CAD) test. A retrospective case series in 36 patients with BCM (ages 6-70) was performed with the FM D-15 test. A subset of six patients also had Roth-28 Hue and CAD tests.

RESULTS: All patients with BCM had abnormal results for D-15, Roth-28, and CAD tests. With D-15, there was protan-deutan confusion and no bimodal tendency. Roth-28 results reinforced that finding. There was symmetry in color vision metrics between the two eyes and coherence between sessions with the arrangement tests and CAD. Severe abnormalities in red-green sensitivity with CAD were expected. Unexpected were different levels of yellow-blue results with two patterns of abnormal thresholds: moderate elevation in two younger patients and severe elevation in four patients ≥35 years. Coefficients of repeatability and intersession means were tabulated for all test modalities.

CONCLUSIONS: Given understanding of advantages, disadvantages, and complexities of interpretation of results, both an arrangement test and CAD should be useful monitors of color vision through a clinical trial in BCM.

TRANSLATIONAL RELEVANCE: Our pilot studies in BCM of arrangement and CAD tests indicated both were clinically feasible and interpretable in the context of this cone gene disease.

Publication Type: Article
Additional Information: This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Publisher Keywords: clinical trial; color; cone photoreceptor; visual pigment gene mutations; outcome measure
Subjects: R Medicine > RE Ophthalmology
Departments: School of Health & Psychological Sciences > Optometry & Visual Sciences
SWORD Depositor:
[thumbnail of i2164-2591-12-1-25_1674547467.12385.pdf]
Preview
Text - Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (3MB) | Preview

Export

Add to AnyAdd to TwitterAdd to FacebookAdd to LinkedinAdd to PinterestAdd to Email

Downloads

Downloads per month over past year

View more statistics

Actions (login required)

Admin Login Admin Login